A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...